Compare ACIU & ANGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ACIU | ANGI |
|---|---|---|
| Founded | 2003 | 1995 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Advertising |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 247.6M | 198.7M |
| IPO Year | 2015 | 2017 |
| Metric | ACIU | ANGI |
|---|---|---|
| Price | $2.76 | $4.72 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 7 |
| Target Price | $10.00 | ★ $17.00 |
| AVG Volume (30 Days) | 194.4K | ★ 764.9K |
| Earning Date | 05-12-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 1242.86 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $736,386,000.00 |
| Revenue This Year | $706.75 | $3.25 |
| Revenue Next Year | $321.13 | $3.76 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 47.60 |
| 52 Week Low | $2.10 | $4.26 |
| 52 Week High | $4.00 | $18.38 |
| Indicator | ACIU | ANGI |
|---|---|---|
| Relative Strength Index (RSI) | 51.79 | 43.93 |
| Support Level | $2.57 | $4.55 |
| Resistance Level | $3.00 | $6.52 |
| Average True Range (ATR) | 0.15 | 0.30 |
| MACD | -0.01 | 0.03 |
| Stochastic Oscillator | 27.38 | 19.08 |
AC Immune SA is a clinical stage biopharmaceutical company advancing a portfolio of programs strategically focused on pioneering Precision Medicine for neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The company has one segment. The company currently focuses mostly of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.
Angi Inc connects quality home service professionals with consumers across different categories, from repairing and remodeling to cleaning and landscaping. It operates through brands like Angi, HomeAdvisor, and Handy. The company has three operating segments, namely, Ads and Leads, Services, and International (Europe and Canada). A majority of its revenue is generated from the Ads and Leads segment, which provides professionals the capability to engage with potential customers, including quoting and invoicing services, and provides consumers with tools and resources to help them find professionals nationwide for home repair, maintenance, and improvement projects. Geographically, the company derives its key revenue from the United States and also has a presence in other countries.